GlassScriptPhysician profile
Kevin Kwok
NPI 1568813723
$314.87
in general payments reported to CMS, 2019-2025
13 companies · $78.44 in 2025
The $78.44 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.47 · 2021: $38.24 · 2022: $20.28 · 2023: $13.85 · 2024: $102 · 2025: $78.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $193.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $50.35 | 2024 | Tyrvaya |
| Optos, INC. | $50.00 | 2019 | |
| Dompe US, INC. | $39.68 | 2021-2024 | Oxervate |
| Abbvie INC. | $33.33 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $25.12 | 2025 | Xdemvy |
| Thea Pharma INC. | $20.28 | 2022 | |
| Alcon Vision LLC | $19.25 | 2025 | Rocklatan |
| Sun Pharmaceutical Industries INC. | $17.72 | 2025 | |
| Sight Sciences, INC. | $16.47 | 2021 | |
| Rxsight INC | $16.35 | 2025 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Johnson & Johnson Surgical Vision, INC. | $13.85 | 2023 | |
| Aerie Pharmaceuticals, INC. | $12.47 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Kwok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.